L&G Pharma Breakthrough
(BIGT)
£7.44
Previous business day’s close price
+£0.12 (+1.63%)
max available period
£6.58
£10.12
30 Jan 18
26 Apr 24
Details
This ETF tracks companies involved in the development and manufacturing of so‑called ‘orphan drugs’, via the Solactive Pharma Breakthrough Value index. Orphan drugs refers to medication that target very rare diseases. This ETF reinvests income.
Ticker: BIGT
ISIN: IE00BF0H7608
Ticker: BIGT
ISIN: IE00BF0H7608
Key information
ETF Breakdown
Idorsia Ltd
3.3%
Sciclone Pharmaceuticals (Holdings
3.1%
Ipsen
2.5%
Astrazeneca plc
2.5%
Merck&Co Inc
2.5%
Kissei Pharmaceutical Co. Ltd
2.4%
CSL Ltd.
2.4%
Genmab
2.4%
Royalty Pharma plc
2.4%
Jazz Pharmaceuticals plc
2.4%
Sarepta Therapeutics Inc
2.4%
Biomarin Pharmaceutical Inc.
2.4%
Eisai Co Ltd
2.4%
Bavarian Nordic A/S
2.3%
United Therapeutics Corp
2.3%
Zeria Pharmaceutical Co. Ltd.
2.3%
Halozyme Therapeutics Inc.
2.3%
Swedish Orphan Biovitrum AB
2.3%
Alnylam Pharmaceuticals Inc
2.3%
Recordati Industria Chimica e Farmaceutica SpA
2.3%
Vertex Pharmaceuticals, Inc.
2.3%
Biogen Inc
2.3%
Johnson&Johnson
2.3%
Sino Biopharmaceutical Ltd.
2.3%
Incyte Corp.
2.3%
Daiichi Sankyo Co., Ltd.
2.3%
Ionis Pharmaceuticals Inc
2.3%
Innovent Biologics Inc
2.2%
JCR Pharmaceuticals Co. Ltd.
2.2%
Takeda Pharmaceutical Co
2.2%
BeiGene Ltd
2.2%
Novartis AG
2.2%
Chugai Ro Co Ltd
2.2%
Pharmamar S.A.
2.2%
Nippon Shinyaku Co. Ltd.
2.2%
Xencor Inc
2.2%
Grifols SA
2.2%
Apellis Pharmaceuticals Inc
2.2%
Kyowa Kirin Co. Ltd.
2.1%
Biocryst Pharmaceuticals Inc.
2.1%
Beijing Innocare Pharmaceutical Technology Co Ltd
2.1%
Ultragenyx Pharmaceutical Inc.
2.0%
Bluebird bio Inc
1.9%
Others
0.1%
No holdings found.
Please try a different search.
Please try a different search.
North America
38.5%
Europe ex‑UK
21.9%
Japan
18.1%
Asia ex‑Japan
4.7%
Emerging Markets
4.4%
UK
2.5%
Rest of the World
10.1%
Healthcare
49.8%
Technology
6.7%
Financial
5.5%
Industrial
2.3%
Sector ‐ Other
35.6%
Why InvestEngine
Unbeatable value
Build your own portfolio commission free or leave it to our experts for just 0.25%.
Zero‑ISA fees. SIPPs from 0.15%.
Full cost details (ETF costs apply)
Zero‑ISA fees. SIPPs from 0.15%.
Full cost details (ETF costs apply)
Choice of 620+ ETFs
Low cost, diversified, index‑tracking of stock markets, bonds and commodities.
View our ETF range
View our ETF range
Actionable insights
Know exactly which companies, sectors and regions are in your portfolio.
Powerful automation
Grow your wealth the easy way with automated investing features
Easy diversification
Fractional investing lets you put as little as £1 in any ETF.
DIY or Managed
Build and manage your own portfolio or leave it to us.
